Prothena Sees Potential In Targeting Amyloid, Validated By Biogen
CEO Gene Kinney Describes Company’s Emerging Alzheimer’s Programs
Prothena CEO Gene Kinney remains optimistic about targeting amyloid in Alzheimer's disease • Source: Prothena Corporation plc (Michelle Pattee) 
